E.E. Geduld’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

E.E. Geduld’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,000	Closed	-$692K	–	184
2015 Q4	$692K	Buy	+11,000	New	+$562K	0.43%	22
2015 Q3	–	Sell	-5,000	Closed	-$258K	–	233
2015 Q2	$258K	Buy	+5,000	New	+$265K	0.16%	141

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

E.E. Geduld's LKFT Position: Q1 2016 in Review

E.E. Geduld sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2016, closing a stake of 11,000 shares — an estimated $692K sold.

E.E. Geduld first reported a position in LKFT in Q2 2015 and held it in 2 quarters. The position peaked at $692K in Q4 2015. 32 funds tracked by Wall St. Rank hold LKFT as of Q1 2016.

E.E. Geduld reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2016 after selling out during the quarter.
E.E. Geduld sold 11,000 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2016, an estimated $692K.
E.E. Geduld first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 2 quarters.
E.E. Geduld's Lakefront Biotherapeutics American Depositary Shares position peaked at $692K in Q4 2015.
32 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2016.

Based on E.E. Geduld's 13F filing for Q1 2016, filed 9 May 2016.